Centro Nacional de Supercomputación-ko ikertzaileekin lankidetzan egindako argitalpenak (16)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis

    The European respiratory journal, Vol. 61, Núm. 3

  3. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

2022

  1. A first update on mapping the human genetic architecture of COVID-19

    Nature

  2. ICU-Acquired Pneumonia Is Associated with Poor Health Post-COVID-19 Syndrome

    Journal of Clinical Medicine, Vol. 11, Núm. 1

  3. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study

    Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864

  4. Metagenomic Mining for Esterases in the Microbial Community of Los Rueldos Acid Mine Drainage Formation

    Frontiers in Microbiology, Vol. 13

  5. Methodology of a Large Multicenter Observational Study of Patients with COVID-19 in Spanish Intensive Care Units

    Archivos de Bronconeumologia, Vol. 58, pp. 22-31

  6. One-year mortality after ICU admission due to COVID-19 infection

    Intensive Care Medicine

  7. Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study

    The Lancet Regional Health - Europe, Vol. 18

  8. Whole-genome sequencing reveals host factors underlying critical COVID-19

    Nature, Vol. 607, Núm. 7917, pp. 97-103

2021

  1. Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19: A 3-Month Prospective Cohort

    Chest, Vol. 160, Núm. 1, pp. 187-198

2018

  1. Determinants and Prediction of Esterase Substrate Promiscuity Patterns

    ACS Chemical Biology, Vol. 13, Núm. 1, pp. 225-234

2016

  1. A genome-wide association study identifies SLC8A3 as a susceptibility locus for ACPA-positive rheumatoid arthritis

    Rheumatology (United Kingdom), Vol. 55, Núm. 6, pp. 1106-1111

  2. Identification of IRX1 as a Risk Locus for Rheumatoid Factor Positivity in Rheumatoid Arthritis in a Genome-Wide Association Study

    Arthritis and Rheumatology, Vol. 68, Núm. 6, pp. 1384-1391

  3. Urine metabolome profiling of immune-mediated inflammatory diseases

    BMC Medicine, Vol. 14, Núm. 1